Sanofi Pasteur, Merck Part Ways On European Vaccines Venture

Sanofi Pasteur MSD - the joint venture in Europe between Sanofi SA's vaccine arm and Merck & Co – is ending after 22 years as the duo believes they can better manage their product portfolios independently.